🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for NET

A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites📍 Los Angeles📍 Grand Rapids📍 Columbus Tanabe Pharma America, Inc. · Tests: MT-4561 Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design NCT07398417Phase 353 sites📍 Glendale📍 Phoenix📍 Tucson Axsome Therapeutics, Inc. · Tests: AXS-14 (Esreboxetine), Placebo Assessment of Retreatment With Lutathera® in Patients With New Progression of Intestinal Well-differenciated NET NCT04954820Phase 228 sites📍 Angers📍 Bordeaux📍 Brest Institut du Cancer de Montpellier - Val d'Aurelle · Tests: Lutathera COronoary Microcirculation Analysis NETwork NCT07498231NA1 site📍 Bialystok Medical University of Bialystok · Tests: Coronary microvascular function assessment, Coronary microvascular function assessment Digital Health Implementation Strategies to Improve Lung Cancer Screening Among Safety-Net Clinics NCT07716280NA1 site📍 Salt Lake City University of Utah · Tests: Text Messages (TM+), Chat bot (CA), Video, Reactive Patient Navigation (RPN), Proactive Patient Navigation (PPN) Group-based Integrative Pain Management in Primary Care Safety Net Clinics NCT06327542NA1 site📍 San Francisco University of California, San Francisco · Tests: Group Acupuncture, Integrative Group Medical Visits Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial NCT05773274Phase 242 sites📍 Birmingham📍 Phoenix📍 Tucson National Cancer Institute (NCI) · Tests: Biospecimen Collection, Cabozantinib, Computed Tomography, Everolimus, Lutetium Lu 177 Dotatate Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). NCT06607692Phase 1, Phase 21 site📍 Boadilla del Monte Fundación de investigación HM · Tests: Olaparib; 177Lu-DOTATATE Nutrition Intervention for Pancreatic Cancer NCT07554560NA2 sites📍 Philadelphia📍 Philadelphia Children's Hospital of Philadelphia · Tests: Structured Lipid Medical Food Genetics of Appendix Cancer Study NCT05734430n/a1 site📍 Nashville Andreana Holowatyj, PhD, MSCI · Tests: Genetic profiling, Retrospective tissue procurement Molecular Imaging of NET Using [C-11]MRB-PET in MS NCT03207464Phase 1, Phase 21 site📍 Boston Brigham and Women's Hospital · Tests: [C-11]Methylreboxetine A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET) NCT06505395Phase 21 site📍 Beijing CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Tests: SYHX2008 injection, Sandostatin LAR@ Inhaled Dornase Alpha to Reduce Respiratory Failure After Severe Trauma NCT03368092Phase 31 site📍 Strasbourg University Hospital, Strasbourg, France · Tests: Dornase Alfa Inhalant Solution [Pulmozyme], Placebos Influence of Tumour and Patient's Related Factors on the Response to Medical Treatments in Well Differentiated GEP-NENs NCT06356467n/a1 site📍 Milan IRCCS San Raffaele Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not NCT07273409NA4 sites📍 Gothenburg📍 Lund📍 Stockholm Uppsala University · Tests: Debulking surgery Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen NCT05056857n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Biospecimen Collection, Electronic Health Record Review Net Clinical Benefit of Edoxaban Versus Apixaban in Patients With Atrial Fibrillation and Coronary Artery Disease NCT07753200Phase 41 site📍 Seoul Samsung Medical Center · Tests: Edoxaban, Apixaban Intra-arterial Hepatic (IAH) Infusion of Radiolabelled Somatostatin Analogs in GEP-NET Patients With Dominant Liver Metastases NCT04837885Phase 24 sites📍 Bordeaux📍 Nîmes📍 Pessac University Hospital, Bordeaux · Tests: Positron emission tomography computed tomography (PET/CT) with Intra-hepatic (IAH) injection, Positron emission tomogra… Alzheimer's National Registry for Treatment and Diagnostics(ALZ-NET) NCT06170268n/a1 site📍 Chicago Alzheimer's Disease and Related Disorders Association, Inc · Tests: Routine Care Documentation A Phase II Study on Adjuvant Vaccination with Dendritic Cells Loaded with Autologous Tumor Homogenate in Resected Stage IV Rare Cancers. NCT04166006Phase 21 site📍 Meldola Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IR… · Tests: Autologous DC vaccine, Interleukin-2 A Platform Study of Epigenetic Therapy Before Prostatectomy in Men With Prostate Cancer NCT06888102EARLY Phase 11 site📍 Los Angeles Edwin Posadas, MD · Tests: Neoadjuvant Epigenetic Therapy Drug-Coated Balloon Primary PCI in ST-Segment Elevation Myocardial Infarction NCT07436429n/a1 site📍 Vienna Medical University of Vienna · Tests: Drug-Coated Balloon Collection of Liquid Biopsy Samples of Neuroendocrine Neoplasms (NEN) Patients - Collection of NET (CollectNET) 2.0, a Study by the BE-FORCE Consortium NCT06541080n/a8 sites📍 Rumst📍 Sint-Niklaas📍 Leuven University Hospital, Antwerp · Tests: Shallow Whole Genome Sequencing (sWGS)-GIPXplore, methylation-sensitive restriction enzymes (MSRE)-Single-molecule mole… SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET) NCT06889493Phase 11 site📍 Miami Peter Hosein, MD · Tests: Seneca Valley Virus-001 (SVV-001), Nivolumab, Ipilimumab Management of Pancreatic Cystic Lesions Using Artificial Intelligence Based on EUS and Multimodal Data NCT07463872n/a2 sites📍 Wuhan📍 Wuhan Huazhong University of Science and Technology · Tests: Cyst-AI model Patient Satisfaction Following Multidisciplinary Cancer Care Assessment in Day Hospital. NCT07560423n/a1 site📍 Martigues Centre Hospitalier de Martigues · Tests: Multidisciplinary Complex Assessment Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD NCT05572632NA3 sites📍 San Francisco📍 San Francisco📍 San Francisco University of California, San Francisco · Tests: COPD Wellness, COPD Wellness Plus+, Usual Care [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers NCT06479811Phase 11 site📍 Bethesda National Cancer Institute (NCI) · Tests: [212Pb]VMT-alpha-NET, [203Pb]VMT-alpha-NET, 68Ga-DOTATATE 61Cu-NODAGA-LM3 PET/CT for the Detection of Neuroendocrine Tumors (COPPER PET in NET) NCT06455358Phase 1, Phase 21 site📍 Basel University Hospital, Basel, Switzerland · Tests: 61Cu-NODAGA-LM3, Comparator Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for Diagnosis and Staging of Neuroblastoma and Pheochromocytoma/Paraganglioma NCT07195500n/a1 site📍 Nanjing Nanjing First Hospital, Nanjing Medical University
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy